• Deferoxamine Mesylate: Iron-Chelating Agent in Experimental

  2026-07-25

  Deferoxamine mesylate is redefining experimental models of iron metabolism, hypoxia signaling, and oxidative stress. This guide offers actionable protocols, troubleshooting, and research-ready workflows to unlock its full potential as a versatile iron-chelating agent.

• Cucurbitacin I (JSI-124): Advanced STAT3 Inhibition Workflow

  2026-07-24

  Cucurbitacin I (JSI-124) stands out as a precise STAT3 pathway inhibitor, enabling reproducible cancer research workflows from cell culture to in vivo models. This guide details optimized protocols, troubleshooting strategies, and practical insights for maximizing STAT3 pathway dissection with APExBIO’s validated Cucurbitacin I.

• CCG-1423: Dissecting RhoA Inhibition for Oncology & Antivira

  2026-07-24

  Explore how CCG-1423, a potent RhoA inhibitor, enables precise dissection of RhoA/ROCK1 signaling in cancer and viral infection models. This article offers advanced mechanistic insight and guides optimal experimental use, delivering unique value for translational researchers.

• BML-277: Precision Chk2 Inhibitor for DNA Damage Response Re

  2026-07-23

  BML-277 empowers researchers to dissect DNA damage response and radioprotection of T-cells with nanomolar Chk2 inhibition and robust ATP-competitive selectivity. New discoveries linking Chk2, cGAS, and L1 retrotransposition position BML-277 as a transformative tool for genome stability, cancer research, and advanced radioprotection assays.

• EdU Imaging Kits (488): Streamlined S-Phase Cell Proliferati

  2026-07-23

  EdU Imaging Kits (488) empower researchers with rapid, high-sensitivity detection of S-phase DNA synthesis—eliminating the harsh steps of BrdU-based assays. Optimized for reproducibility and compatibility with diverse applications, these kits are transforming cell proliferation analysis in disease modeling and regenerative research.

• WNT Signaling Drives Biliary Proliferation After Duct Obstru

  2026-07-22

  This study reveals that WNT signaling, specifically via β-catenin, is a central driver of cholangiocyte proliferation in response to extrahepatic bile duct obstruction in mice. The findings clarify key mechanisms underlying cholangiopathies and offer a robust experimental framework for dissecting developmental pathway involvement in biliary injury.

• Anagliptin-Induced Vasorelaxation: Kv Channels and SERCA Pum

  2026-07-22

  This study demonstrates that anagliptin, a DPP-4 inhibitor, induces vasorelaxation in rabbit aorta by activating voltage-dependent K+ (Kv) channels and the SERCA pump, independent of endothelial or cyclic nucleotide pathways. These findings clarify anagliptin’s direct mechanisms in vascular physiology and provide a basis for research on cardiovascular safety in diabetes.

• Aconitase Assays: Advancing Immunometabolic Research Frontie

  2026-07-21

  Explore how APExBIO's Aconitase Activity Colorimetric Assay Kit (K2226) unlocks new potential in immunometabolic and translational research. This article bridges mechanistic insights on iron-sulfur protein aconitase and TCA cycle dynamics with actionable strategies for researchers targeting oxidative stress and metabolic reprogramming, referencing recent advances in CD8+ T cell metabolism.

• Phosphatase Inhibitor Cocktail 1: Precision in Protein Phosp

  2026-07-21

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) elevates protein phosphorylation preservation, empowering robust phosphoproteomic and signaling pathway analyses. Its unique formulation targets both alkaline and serine/threonine phosphatases, offering unmatched flexibility across Western blotting, immunoprecipitation, and kinase assays.

• BML-277: Selective Chk2 Inhibitor for Radioprotection Resear

  2026-07-20

  BML-277 is a potent and selective Chk2 inhibitor with nanomolar affinity, enabling precise study of DNA damage response and radioprotection of T-cells. Its ATP-competitive mechanism and validated purity support reproducible kinase inhibition assays. APExBIO supplies BML-277 for advanced cancer and genome integrity research.

• Cefoperazone Sodium Salt: Optimized Protocols for Antibacter

  2026-07-20

  Cefoperazone (sodium salt) is a β-lactamase-stable, broad-spectrum cephalosporin uniquely suited for rigorous in vitro antimicrobial activity assays and translational models of gram-negative resistance. This article delivers protocol-ready workflows, troubleshooting strategies, and advanced comparative insights rooted in landmark reference studies and APExBIO’s trusted supply.

• Brefeldin A: Mechanistic Leverage for Translational Cancer R

  2026-07-19

  This article delivers a thought-leadership perspective on Brefeldin A (BFA) as a transformative tool in cancer and endothelial biology. We bridge mechanistic insight with actionable protocol guidance, drawing from recent biomarker studies and advanced workflow strategies, to help translational researchers harness BFA’s full potential in modeling ER stress, apoptosis, and protein trafficking. By contextualizing BFA's unique capabilities within the evolving landscape of cancer and sepsis research, we illuminate new translational frontiers beyond conventional product pages.

• EdU Imaging Kits (Cy3): Precision S-Phase Detection Meets Tr

  2026-07-18

  Explore how EdU Imaging Kits (Cy3) enable precise, non-destructive measurement of cell proliferation through S-phase DNA synthesis. This article reveals advanced assay design considerations, translational oncology applications, and unique insights from recent ferroptosis research.

• Phosphatase Inhibitor Cocktail 3: Advanced Strategies for Pr

  2026-07-17

  Explore the advanced scientific basis and unique applications of Phosphatase Inhibitor Cocktail 3 (100X in DMSO) for robust serine/threonine phosphatase inhibition and protein phosphorylation preservation. This article provides deep insight into its mechanism, protocol optimization, and practical value for cutting-edge phosphoprotein analysis.

• Nuclear cGAS-TRIM41 Axis Suppresses L1 Retrotransposition vi

  2026-07-17

  The referenced study reveals that nuclear cGAS restricts LINE-1 (L1) retrotransposition by facilitating TRIM41-mediated ubiquitination and degradation of ORF2p, a process dependent on Chk2-mediated phosphorylation of cGAS in response to DNA damage. These findings clarify a nuclear role for cGAS in maintaining genome integrity and offer mechanistic insight relevant to aging and cancer biology.

15205 records 1/1014 page Next 12345 下5页 Last page